Is the Price of Mounjaro Going Down in the UK?

Why did Mounjaro's price go up, not down?

When a medicine is still under patent and demand is running well ahead of supply, the manufacturer holds most of the pricing power. Eli Lilly's September 2025 list-price increase was steep (the 15mg pen moved from roughly £122 to roughly £330 at list) and private pharmacies set their own retail prices from that base. Widely reported figures since then put typical private-market pricing somewhere between £149 and £375 per month depending on dose and provider, though these figures should be treated as indicative rather than fixed, since they shift with stock, dose and supplier margins.

Competition from a generic or biosimilar version of tirzepatide would be the most reliable route to lower prices, but tirzepatide remains under patent protection and no biosimilar timeline has been confirmed for the UK market. If you are wondering whether Mounjaro is going to come down in price, our dedicated piece examines the patent position, biosimilar timelines and other factors most likely to move the dial. There is also a detailed look at whether prices are likely to soften at all in our piece on whether the price of Mounjaro will go down in the UK, which tracks the factors most likely to move the dial.

Increased NHS commissioning could indirectly affect private demand, which might ease some pressure. But the cost trajectory has been upward, not downward, and it is sensible to budget on the basis of current pricing rather than a speculative future reduction.

What does a private Mounjaro price actually need to cover?

A figure quoted per month by any legitimate provider needs to fund more than just the pen sitting in your fridge door. At minimum it must include the prescriber's clinical assessment, the actual prescription document, the medicine itself, and delivery. Many headline prices do not include all of these.

Consultation fees can be charged separately, sometimes £30 to £50 before you even know whether you qualify. Prescription fees are sometimes itemised on top. Delivery charges are common, particularly for temperature-controlled medicines that need tracked, refrigerated or next-day handling. And ongoing clinical oversight (someone qualified to review your dose increases, answer questions between orders, and flag if your weight or health picture changes) is often absent entirely from low-headline-price services.

Our Mounjaro price guide covers what a fair total cost of treatment looks like across a full course, which is a more useful number than any single-pen figure. The Mounjaro treatment overview explains the dose schedule that determines how many pens a course typically involves.

Is 'cheapest' a useful target when comparing Mounjaro providers?

For most purchases, cheapest is a reasonable starting point. For a prescription medicine supplied by injection, it is the wrong question. The risk with the lowest-priced listings is not just poor service, it is counterfeit supply. The MHRA has warned repeatedly about fake weight-loss pens sold through social media and unofficial websites; in October 2025 the agency raided the first known illicit UK manufacturing site producing counterfeit tirzepatide pens, having already seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million. Fake pens have been found to contain insulin rather than tirzepatide, a serious and potentially life-threatening difference.

You can verify any online pharmacy on the GPhC register; a legitimate provider will have a GPhC premises registration number they are happy for you to check. Sellers offering these medicines without a prescription, or with prices dramatically below the market range described above, are a red flag worth taking seriously. The MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk allows you to report suspect sellers directly.

A small saving on a pen that turns out to be counterfeit is not a saving at all. Price is simply the wrong test for a prescription medicine.

So where does nume sit on price?

We are not trying to be the cheapest option, and we are transparent about that. What we offer instead is one price that covers everything: your consultation, the prescriber's review, the prescription, the medicine, and free next-working-day delivery via DPD in plain packaging. There are no add-on fees, no subscription and no automatic renewal. A real clinician (a GPhC-registered Independent Prescriber) reads your consultation personally, every time you order.

If you want to understand the broader picture of whether Mounjaro prices are easing across the market, or you're trying to work out whether prices are still rising, those pages set out what the evidence currently shows. For anyone wondering whether the right moment to start is now or later, our prescribers are the right people to talk to. Speak to our prescribers through a free consultation, there is no obligation, and you will know the full cost before anything is dispensed.